179 related articles for article (PubMed ID: 9499690)
1. NSAIDs: a critical appraisal.
Jacobs JW; Bijlsma JW
Neth J Med; 1997 Dec; 51(6):198-204. PubMed ID: 9499690
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
Whittle BJ
Fundam Clin Pharmacol; 2003 Jun; 17(3):301-13. PubMed ID: 12803569
[TBL] [Abstract][Full Text] [Related]
3. NSAID gastroenteropathy: past, present and future.
Wallace JL
Can J Gastroenterol; 1996; 10(7):451-9. PubMed ID: 9113889
[TBL] [Abstract][Full Text] [Related]
4. COX-2-Selective NSAIDs: new and improved?
Lichtenstein DR; Wolfe MM
JAMA; 2000 Sep; 284(10):1297-9. PubMed ID: 10980759
[No Abstract] [Full Text] [Related]
5. Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited.
Lichtenberger LM
Biochem Pharmacol; 2001 Mar; 61(6):631-7. PubMed ID: 11266647
[TBL] [Abstract][Full Text] [Related]
6. Forthcoming non-steroidal anti-inflammatory drugs: are they really devoid of side effects?
Bjarnason I
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S27-36. PubMed ID: 10379467
[TBL] [Abstract][Full Text] [Related]
7. NSAIDs: gastroprotection or selective COX-2 inhibitors?
Davis MP
Palliat Med; 2005 Mar; 19(2):165; author reply 166-7. PubMed ID: 15810759
[No Abstract] [Full Text] [Related]
8. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword.
Lichtenstein DR; Syngal S; Wolfe MM
Arthritis Rheum; 1995 Jan; 38(1):5-18. PubMed ID: 7818572
[No Abstract] [Full Text] [Related]
9. Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract.
James MW; Hawkey CJ
Br J Clin Pharmacol; 2003 Aug; 56(2):146-55. PubMed ID: 12895187
[TBL] [Abstract][Full Text] [Related]
10. Non steroidal anti-inflammatory drugs. Minimising the harm, maximising the benefit.
Hawkey CJ
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):48-9. PubMed ID: 9615265
[No Abstract] [Full Text] [Related]
11. Endoscopic aspects of gastroduodenal mucosa due to NSAIDs.
Ruina M; Caselli M; Sartori S; Trevisani L; La Corte R; Trotta F; Alvisi V
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():9-11. PubMed ID: 9032574
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors.
Perini R; Fiorucci S; Wallace JL
Can J Gastroenterol; 2004 Apr; 18(4):229-36. PubMed ID: 15054499
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of NSAID-induced gastrointestinal mucosal injury: a basis for preventing ulceration and symptoms from these agents.
Rainsford KD
Aliment Pharmacol Ther; 1988; 2 Suppl 1():43-55. PubMed ID: 2979284
[TBL] [Abstract][Full Text] [Related]
15. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
Agrawal NM; Saggioro A
J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
[TBL] [Abstract][Full Text] [Related]
16. The future of NSAID therapy: selective COX-2 inhibitors.
Vane JR; Botting RM
Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
[No Abstract] [Full Text] [Related]
17. [Finally anti-inflammatory agents less damaging to the stomach?].
Piqué JM
Gastroenterol Hepatol; 2000 Feb; 23(2):87-9. PubMed ID: 10726390
[No Abstract] [Full Text] [Related]
18. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
Laine L
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological bases of non-steroidal anti-inflammatory analgesics].
Beltrán B; Moreno L; Esplugues JV
Gastroenterol Hepatol; 1996 Nov; 19(9):478-88. PubMed ID: 8998674
[No Abstract] [Full Text] [Related]
20. Cyclooxygenase and nitric oxide systems in the gut as therapeutic targets for safer anti-inflammatory drugs.
Whittle BJ
Curr Opin Pharmacol; 2004 Dec; 4(6):538-45. PubMed ID: 15525540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
